C&D Emerging Industry Equity Investment focuses on national strategic emerging industries, particularly healthcare, advanced manufacturing, and TMT/consumption sectors. Its strategy involves empowering emerging enterprises and leveraging the industrial resources and brand influence of its parent company, C&D Group, to create new value and foster stronger development.
50% of their portfolio is in AI. They made 1 investments in the last 12 months. Their most common stage is series-a (50% of deals).
Portfolio
2
Fund Size
$25B
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 ShengShu Technology | Series A | — | Feb 2026 |
| OOricell Therapeutics Co., Ltd | Series B | $45M | Feb 2023 |
Top Co-Investors
Last updated: 16 April 2026